Important molecular genetic markers of colorectal cancer

被引：86

作者：

Kudryavtseva, Anna V. ^{[1
,2
]}

Lipatova, Anastasia V. ^{[1
]}

Zaretsky, Andrew R. ^{[3
]}

Moskalev, Alexey A. ^{[1
]}

Fedorova, Maria S. ^{[1
,2
]}

Rasskazova, Anastasiya S. ^{[1
]}

Shibukhova, Galina A. ^{[2
]}

Snezhkina, Anastasiya V. ^{[1
]}

Kaprin, Andrey D. ^{[2
]}

Alekseev, Boris Y. ^{[2
]}

Dmitriev, Alexey A. ^{[1
]}

Krasnov, George S. ^{[1
,4
]}

机构：

[1] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia

[2] Minist Healthcare Russian Federat, Natl Med Res Radiol Ctr, Moscow, Russia

[3] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia

[4] Russian Acad Med Sci, Orekhovich Inst Biomed Chem, Moscow, Russia

来源：

ONCOTARGET | 2016年 / 7卷 / 33期

基金：

俄罗斯科学基金会;

关键词：

colorectal cancer; molecular markers; chromosomal instability; microsatellite instability; CpG island methylator phenotype; ISLAND METHYLATOR PHENOTYPE; OXALIPLATIN-BASED CHEMOTHERAPY; MESSENGER-RNA EXPRESSION; POPULATION-BASED SERIES; APC TUMOR-SUPPRESSOR; AURORA-A EXPRESSION; NF-KAPPA-B; MICROSATELLITE-INSTABILITY; COLON-CANCER; CHROMOSOMAL INSTABILITY;

D O I：

10.18632/oncotarget.9796

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Colorectal cancer (CRC) ranks third in the incidences of cancer morbidity and mortality worldwide. CRC is rather heterogeneous with regard to molecular genetic characteristics and pathogenic pathways. A wide spectrum of biomarkers is used for molecular subtype determination, prognosis, and estimation of sensitivity to different drugs in practice. These biomarkers can include germline and somatic mutations, chromosomal aberrations, genomic abnormalities, gene expression alterations at mRNA or protein level and changes in DNA methylation status. In the present review we discuss the most important and well-studied CRC biomarkers, and their potential clinical significance and current approaches to molecular classification of colorectal tumors.

引用

页码：53959 / 53983

页数：25

共 50 条

[1] Molecular pathways in colorectal cancer
Al-Sohaily, Sam
Biankin, Andrew
Leong, Rupert
Kohonen-Corish, Maija
Warusavitarne, Janindra
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (09) : 1423 - 1431
[2] The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy
Ha Thi Nguyen
Hong-Quan Duong
ONCOLOGY LETTERS, 2018, 16 (01) : 9 - 18
[3] Genetic and biological hallmarks of colorectal cancer
Li, Jiexi
Ma, Xingdi
Chakravarti, Deepavali
Shalapour, Shabnam
DePinho, Ronald A.
GENES & DEVELOPMENT, 2021, 35 (11-12) : 787 - 820
[4] Genetic Molecular Subtypes in Optimizing Personalized Therapy for Metastatic Colorectal Cancer
Wlodarczyk, Marcin
Wlodarczyk, Jakub
Siwinski, Pawel
Sobolewska-Wlodarczyk, Aleksandra
Fichna, Jakub
CURRENT DRUG TARGETS, 2018, 19 (15) : 1731 - 1737
[5] Predictive molecular markers for the treatment with immune checkpoint inhibitors in colorectal cancer
Du, Fenqi
Liu, Yanlong
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (01)
[6] The role of tumour markers and biomarkers in colorectal cancer
Lech, G.
Slotwinski, R.
Krasnodebski, I. W.
NEOPLASMA, 2014, 61 (01) : 1 - 8
[7] Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer
Coppede, Fabio
Lopomo, Angela
Spisni, Roberto
Migliore, Lucia
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (04) : 943 - 956
[8] Molecular subtyping in colorectal cancer: A bridge to personalized therapy (Review)
Wang, Chunlin
Zhang, Hao
Liu, Yunxiao
Wang, Yuliuming
Hu, Hanqing
Wang, Guiyu
ONCOLOGY LETTERS, 2023, 25 (06)
[9] The Use of Molecular Markers in the Diagnosis of Colorectal Cancer Screening
Schmid, Gerald
DIGESTIVE DISEASES, 2010, 28 (4-5) : 625 - 628
[10] The Molecular Pathogenesis of Colorectal Cancer and Its Potential Application to Colorectal Cancer Screening
Grady, William M.
Markowitz, Sanford D.
DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (03) : 762 - 772

← 1 2 3 4 5 →